Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb;13(2):852-60.
doi: 10.1128/mcb.13.2.852-860.1993.

N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65

Affiliations

N-terminal DNA-binding domains contribute to differential DNA-binding specificities of NF-kappa B p50 and p65

M B Toledano et al. Mol Cell Biol. 1993 Feb.

Abstract

We previously reported that either oxidation or alkylation of NF-kappa B in vitro abrogates DNA binding. We used this phenomenon to help elucidate structural determinants of NF-kappa B binding. We now demonstrate that Cys-62 of NF-kappa B p50 mediates the redox effect and lies within an N-terminal region required for DNA binding but not for dimerization. Several point mutations in this region confer a transdominant negative binding phenotype to p50. The region is highly conserved in all Rel family proteins, and we have determined that it is also critical for DNA binding of NF-kappa B p65. Replacement of the N-terminal region of p65 with the corresponding region from p50 changes its DNA-binding specificity towards that of p50. These data suggest that the N-terminal regions of p50 and p65 are critical for DNA binding and help determine the DNA-binding specificities of p50 and p65. We have defined within the N-terminal region a sequence motif, R(F/G)(R/K)YXCE, which is present in Rel family proteins and also in zinc finger proteins capable of binding to kappa B sites. The potential significance of this finding is discussed.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1988 Oct 28;242(4878):540-6 - PubMed
    1. Nature. 1988 Sep 22;335(6188):321-9 - PubMed
    1. Science. 1989 Apr 28;244(4903):466-9 - PubMed
    1. Cell. 1989 Jul 28;58(2):227-9 - PubMed
    1. Oncogene. 1989 Jul;4(7):935-42 - PubMed